Oncolys BioPharma, Inc. Financial Overview
Oncolys BioPharma, Inc.'s market cap is currently ¥26.77B. The company's EPS TTM is ¥-11.78; its P/E ratio is -10.47; Oncolys BioPharma, Inc. is scheduled to report earnings on November 7, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
